药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etidronic acid
Racepinephrine
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Racepinephrine.
Etidronic acid
Doxofylline
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Doxofylline.
Etidronic acid
Olodaterol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Olodaterol.
Etidronic acid
Hexoprenaline
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Hexoprenaline.
Etidronic acid
Protokylol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Protokylol.
Etidronic acid
Droxidopa
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Droxidopa.
Etidronic acid
Indacaterol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Indacaterol.
Etidronic acid
Celiprolol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Celiprolol.
Etidronic acid
Clenbuterol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Clenbuterol.
Etidronic acid
Procaterol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Procaterol.
Etidronic acid
Ephedra sinica root
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Ephedra sinica root.
Etidronic acid
Pirbuterol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Pirbuterol.
Etidronic acid
Fenoterol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Fenoterol.
Etidronic acid
Arformoterol
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Arformoterol.
Etidronic acid
Arbutamine
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Arbutamine.
Etidronic acid
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aldosterone.
Etidronic acid
Hyaluronidase (human recombinant)
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Aldosterone.
Etidronic acid
Deferasirox
The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Aldosterone is combined with Deferasirox.
Etidronic acid
Corticorelin ovine triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Aldosterone.
Etidronic acid
Ceritinib
The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Ceritinib.